The institutional review board approved the chemotherapy and MIBG imaging protocols and informed written consent was obtained from all patients. 1. However, when FDA is unavailable, DOPA-PET or MIBG scintigraphy can be used as valid alternatives[None]. CT and MR imaging are excellent for detecting mass lesions and for following their size during therapy. Another limitation is that pathologic data were not available to compare with the changes evident on MIBG imaging. 